申请人:SMITHKLINE BECKMAN CORPORATION
公开号:EP0209275A1
公开(公告)日:1987-01-21
The invention relates to compounds of the formula:
wherein R1 and R2 are each hydrogen, n-propyl, n-butyl or 4-hydroxyphenetyl;
X is hydrogen or halo; and Y is hydrogen or halo provided that one of X and Y is halo and the other is hydrogen. Also disclosed are methods for the preparation of the compounds, pharmaceutical compositions containing them and their activity as dopaminergic receptor antagonists.
本发明涉及式的化合物:
其中 R1 和 R2 各为氢、正丙基、正丁基或 4-羟基苯乙基;
X为氢或卤代;Y为氢或卤代,条件是X和Y中的一个为卤代,另一个为氢。还公开了制备这些化合物的方法、含有这些化合物的药物组合物及其作为多巴胺能受体拮抗剂的活性。